statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024 Sera Prognostics Announces Conference Call and Webcast of First Quarter...

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024

Sera Prognostics, Inc. (NASDAQ:SERA  Get Free Report) CEO Zhenya Lindgardt sold 38,899 shares of the stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an...

Sera Prognostics, Inc. (NASDAQ:SERA) CEO Sells $364,483.63 in Stock

Sera Prognostics, Inc. (NASDAQ:SERA  Get Free Report) insider John J. Boniface sold 21,438 shares of the firms stock in a transaction dated Tuesday, March 26th. The stock was sold at an...

John J. Boniface Sells 21,438 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) Stock

Sera Prognostics, Inc. (NASDAQ:SERA  Get Free Report) CFO Austin Aerts sold 8,092 shares of Sera Prognostics stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at...

Sera Prognostics, Inc. (NASDAQ:SERA) CFO Austin Aerts Sells 8,092 Shares

Chief Scientific Officer John Boniface Sells 22,163 Shares of Sera Prognostics Inc (SERA)

Chief Scientific Officer John Boniface Sells 21,438 Shares of Sera Prognostics Inc (SERA)

Sera Prognostics' PreTRM: A Speculative Buy In Women's Health...

Sera Prognostics' PreTRM: A Speculative Buy In Women's Health

Sera Prognostics, Inc (SERA) Q4 2023 Earnings Call Transcript...

Sera Prognostics, Inc (SERA) Q4 2023 Earnings Call Transcript

Q4 and Full Year 2023 Financials Indicate Reduced Losses and Operating ExpensesRelated Stocks: SERA...

Sera Prognostics Inc Reports Modest Revenue Growth Amid Operational Streamlining

Sera Prognostics: Q4 Earnings Insights

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

Volume	33,313.00
52-Wk High	$12.36
52-Wk Low	$1.52

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.27	--	--	N/A
Q4'23	-$0.26	-$0.25	3.10%	BEAT
Q3'23	-$0.34	-$0.23	31.55%	BEAT
Q2'23	-$0.36	-$0.34	4.85%	BEAT
Q1'23	-$0.38	-$0.34	10.40%	BEAT

SERA Sera Prognostics Inc

About

Feed

News

Earnings

Fundamentals